Track the Almirall, S.A. stock price and the full management transaction log of the company, a listed equity based in Spain. Shares trade on ES ES, under the authority of CNMV. Operating in the Health Care sector, Almirall, S.A. has published 0 public disclosures. Market capitalisation: €2.4bn. The full history is accessible without an account.
Analysts rate Almirall, S.A. Buy (bullish), based on 12 analysts. Average price target: €14.51.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Almirall, S.A. is a Spanish pharmaceutical company focused on developing dermatological treatments and medications for other therapeutic areas. It is listed on the Spanish stock market, XMAD.